In fact, a median OS of 35 months in patients undergoing to 6 cycles of TMZ might be influenced by IDH mutation since none of the patients are reported to undergo to tumor treating fields; while a median OS of 23 months may be related with a high prevalence of MGMT methylated patients, for example. The gene discussed is MGMT; the disease is neoplasm.